These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31707701)

  • 1. Correlation Between Allosteric and Orthosteric Sites.
    Zhang W; Xie J; Lai L
    Adv Exp Med Biol; 2019; 1163():89-105. PubMed ID: 31707701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated.
    Ma X; Meng H; Lai L
    J Chem Inf Model; 2016 Sep; 56(9):1725-33. PubMed ID: 27580047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Computational Identification of Allosteric Sites and Pathways in Proteins.
    Daura X
    Adv Exp Med Biol; 2019; 1163():141-169. PubMed ID: 31707703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperativity between the orthosteric and allosteric ligand binding sites of RORĪ³t.
    de Vries RMJM; Meijer FA; Doveston RG; Leijten-van de Gevel IA; Brunsveld L
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Allosteric Database.
    Song K; Zhang J; Lu S
    Adv Exp Med Biol; 2019; 1163():65-87. PubMed ID: 31707700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
    Keov P; Sexton PM; Christopoulos A
    Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in NMR Methods to Identify Allosteric Sites and Allosteric Ligands.
    Abdelkarim H; Hitchinson B; Banerjee A; Gaponenko V
    Adv Exp Med Biol; 2019; 1163():171-186. PubMed ID: 31707704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed dualsteric modulators: A novel route for drug discovery.
    Li N; Zheng G; Fu L; Liu N; Chen T; Lu S
    Drug Discov Today; 2024 Oct; 29(10):104141. PubMed ID: 39168404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.
    Wagner JR; Lee CT; Durrant JD; Malmstrom RD; Feher VA; Amaro RE
    Chem Rev; 2016 Jun; 116(11):6370-90. PubMed ID: 27074285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling allosteric landscapes of allosterome with ASD.
    Liu X; Lu S; Song K; Shen Q; Ni D; Li Q; He X; Zhang H; Wang Q; Chen Y; Li X; Wu J; Sheng C; Chen G; Liu Y; Lu X; Zhang J
    Nucleic Acids Res; 2020 Jan; 48(D1):D394-D401. PubMed ID: 31665428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Binding Pockets Versus Allosteric Binding.
    Song K; Zhang J
    Methods Mol Biol; 2018; 1825():295-326. PubMed ID: 30334210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.